Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines

BACKGROUND: Despite encouraging results with the proteasome inhibitor bortezomib in the treatment of hematologic malignancies, emergence of resistance can limit its efficacy, hence calling for novel strategies to overcome bortezomib-resistance. We previously showed that bortezomib-resistant human le...

Descripción completa

Detalles Bibliográficos
Autores principales: Niewerth, Denise, Kaspers, Gertjan JL, Assaraf, Yehuda G, van Meerloo, Johan, Kirk, Christopher J, Anderl, Janet, Blank, Jonathan L, van de Ven, Peter M, Zweegman, Sonja, Jansen, Gerrit, Cloos, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896789/
https://www.ncbi.nlm.nih.gov/pubmed/24418325
http://dx.doi.org/10.1186/1756-8722-7-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896789/
https://www.ncbi.nlm.nih.gov/pubmed/24418325
http://dx.doi.org/10.1186/1756-8722-7-7

Ejemplares similares